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Abstract
Background: Burns cause devastating injuries and a high incidence of severe physical and psychological
impairment. Severe burns require specialized medical professionals and facilities for optimal recovery that
require multiple surgeries, long hospital stays and rehabilitation. Surgical debridement and skin grafting is the
standard of care for most burn patients. Maggot Debridement Therapy (MDT) is a modality that might be
useful as an alternative to surgical debridement for wound bed preparation. This could be an excellent
alternative to wound debridement for patients that are not surgical candidates. This review looks at the
efficacy of MDT for debridement of acute burn patients.
Methods: An exhaustive systematic literature review was performed using MEDLINE-Ovid, Web of Science,
CINAHL and Google Scholar utilizing the keywords maggot therapy, larvae therapy and burns.
Results: A total of 143 articles were screened with 7 case studies meeting designated criterion reviewed.
Maggot debridement therapy was found to be effective in removal of necrotic tissue from these burn wounds
in 6 out of 7 cases. The case report where debridement was not successful was due to burn destruction into
the knee joint capsule and MDT was terminated secondary to the need for bilateral knee amputation. The
number of MDT treatments required to obtain full debridement ranged from 2-5 applications. The overall
quality of these studies via the GRADE criteria is very low due to there being no RCTs performed at the time
of this review and further studies need to be performed on a larger population of patients with acute burns.
Conclusion: Based on these case reports, MDT should be considered for the burn patient population as a
rapid, effective, safe and economical alternative modality for wound management.
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Abstract  
Background: Burns cause devastating injuries and a high incidence of severe physical and 
psychological impairment. Severe burns require specialized medical professionals and facilities 
for optimal recovery that require multiple surgeries, long hospital stays and rehabilitation. 
Surgical debridement and skin grafting is the standard of care for most burn patients. Maggot 
Debridement Therapy (MDT) is a modality that might be useful as an alternative to surgical 
debridement for wound bed preparation. This could be an excellent alternative to wound 
debridement for patients that are not surgical candidates. This review looks at the efficacy of 
MDT for debridement of acute burn patients. 
Methods: An exhaustive systematic literature review was performed using MEDLINE-Ovid, 
Web of Science, CINAHL and Google Scholar utilizing the keywords maggot therapy, larvae 
therapy and burns.  
Results:  A total of 143 articles were screened with 7 case studies meeting designated criterion 
reviewed. Maggot debridement therapy was found to be effective in removal of necrotic tissue 
from these burn wounds in 6 out of 7 cases. The case report where debridement was not 
successful was due to burn destruction into the knee joint capsule and MDT was terminated 
secondary to the need for bilateral knee amputation. The number of MDT treatments required to 
obtain full debridement ranged from 2-5 applications. The overall quality of these studies via the 
GRADE criteria is very low due to there being no RCTs performed at the time of this review and 
further studies need to be performed on a larger population of patients with acute burns. 
Conclusion:  Based on these case reports, MDT should be considered for the burn patient 
population as a rapid, effective, safe and economical alternative modality for wound 
management.  
Keywords:  Maggot therapy, larvae therapy, burns. 
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 Burns cause devastating injuries and a high incidence of severe physical and 
psychological impairment. Disabilities ranging from disfiguring scars, contractures, amputations, 
anxiety and depression are common. Mortality rates vary depending on the extent of the burn and 
if inhalation injuries are involved.1 Survival is largely dependent on early intervention with fluid 
resuscitation and early wound excision. Wound infection and skin graft rejection is a major 
concern adding to post injury complications. Classically, debridement of necrotic tissue from 
burn injuries is done surgically often requiring multiple operations as skin grafting and 
reconstruction are common. Management of burn patients is multi-disciplinary including a 
specialized surgical team, nursing, social services, behavioral health, physical therapy, 
occupational therapy, respiratory therapy and speech therapy. Often advance wound dressings, 
splints, compression garments and prostheses are necessary to optimize function and mobility 
with the goal to improve the overall quality of life. Many patients experience severe pain 
complicated by dressing changes and multiple surgical interventions that can take weeks to 
months to heal which result in long costly hospital stays for these patients.2  
 Although maggot debridement therapy (MDT) has hundreds of years of documented 
success for wound debridement, their use for acute burn patients is a new area of research. 
Exploring alternative methods to surgery to reduce pain and recovery time for burn patients is an 
important step in advancing burn wound care. Maggots have been documented to be adventitious 
for debridement of battle wounds since antiquity. The first intentional MDT application into a 
wound was during the American Civil War by a Confederate army surgeon named J.F. Zacharias 
who found that the soldiers infested with maggots had a much higher survival rate and faster 
healing times.3 In 1917, during World War I, an orthopedic surgeon named William S. Baer 
recognized the benefit of maggots in soldiers with open femur fractures. Baer noted no purulence 
or infection of the wounds after maggot removal and the wounds were covered with healthy pink 
granulation tissue often extending over the exposed bone. This occurred in a time where open 
femur fractures resulted in an 80% mortality rate. Baer popularized maggot therapy in the United 
States during the 1930’s for use in osteomyelitis infections and formulated a method to raise and 
sterilize the eggs of the green blow fly.4 Thousands of physicians utilized maggots until the 
1940’s when the invention of antibiotics became widely available which greatly reduced the 
popularity of the use of maggots.5 Although MDT has hundreds of years of documented success 
for wound debridement, their use for the burn patients is a new area of research. 
 Medicinal maggots are larvae from the green blow fly of the species Phaenicia sericata. 
The use of these maggots is due to their specificity of consuming only necrotic tissue leaving 
viable tissue untouched.6 The eggs are disinfected with 3% Lysol solution for 5-6 minutes7 or 
0.525% sodium hypochlorite8 then rinsed with sterile saline and placed in sterile containers with 
a sterile food source for incubation. Each sterile container holds 250-500 maggots.5  Generally 5-
10 maggots/cm2 are placed into the wound and covered with a fine mesh to ensure adequate 
oxygenation and then lightly covered with an absorbent pad and left in place for 2-3 days.7 
Maggots are known to promote wound healing by multiple actions: 
 Wound debridement by utilizing necrotic tissue as their food source. The maggots have 
proteolytic enzymes that liquefy dead tissue within 48-72 hours. This process produces 
copious exudate that irrigates the wound during the digestion process.3,6 
 The mechanical action of the maggots crawling in the wound bed stimulates rapid 
granulation tissue formation.3,8 
  Maggot secretions possess broad spectrum antimicrobial activity with further 
bactericidal action within the stomach of the maggot.6 
 Reduction of biofilm formation of MRSA and Pseudomonas aeurginosa.9 
In 2004, the U.S. Food and Drug Administration (FDA) authorized a licensed practitioner to 
prescribe medical maggot use in humans and animals for treatment of pressure ulcers, diabetic 
foot ulcers, venous stasis ulcers, post-surgical wound and non-healing traumatic wounds. To 
date, it is not FDA approved for the treatment of acute burns. While MDT is well documented to 
be a successful modality for wound debridement in many types of wounds, the question of the 
benefit in acute burn wounds still remains to be answered. 
METHODS 
 An exhaustive systematic literature review was performed using MEDLINE-Ovid, Web 
of Science, CINAHL and Google Scholar utilizing the keywords maggot therapy, larvae therapy 
and burns. Articles were screened and references were reviewed for relevance using inclusion 
criteria of human studies and studies published in the English language. Animal studies were 
excluded. There are no controlled clinical studies using MDT on burn wounds published at the 
time of this review, therefore case reports were selected and cross referenced. The Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE) criterion was used to 
evaluate the level of evidence quality.10 
RESULTS 
 A total of 143 articles were screened with 7 case studies meeting designated criterion 
reviewed. The information provided by these case reports was incredibly limited and inconsistent 
with available details summarized. (See Table I.) 
 Case 1: A 72 year old male with diabetes, heart disease and vascular disease sustained an 
upper arm burn and was deemed medically unfit for surgery. This patient achieved 
complete debridement with 4 maggot applications and underwent a split thickness skin 
graft with complete healing after 3 weeks from initiation of MDT. It was predicted that 
wound healing would have taken 6-8 weeks with standard dressings.2   
 Case 2: A 32 year old male with spina bifida sustained a full thickness friction burn of his 
right foot. This patient was unwilling to have surgery due to not wanting another scar. 
With 5 MDT applications he achieved complete debridement and wound closure in 51 
days. Maggot therapy allowed this patient to stay out of the hospital and play an active 
decision making role in his care.2 (Figure I.) 
 Case 3: A 64 year old male with myasthenia gravis had bilateral knee burns from a 
campfire. After 2 failed grafts, MDT was initiated and larvae were found to be burrowing 
into the joint capsule. Due to the extensive invasion of soft tissue structures this patient 
underwent bilateral amputations. Edwards speculates that if MDT was initiated earlier, 
then the painful failed prior skin graft surgeries could have been avoided.2 
 Case 4:  A 41 year old male suffered from 9% total body surface area (TBSA) burns on 
his legs from sleeping by a campfire and underwent 2 failed surgical debridement with 
autografting, 13 hyperbaric oxygen therapy treatments, and burr holes were drilled into 
his tibia to promote granulation tissue along with sharp debridement. Grafting failure was 
due to residual failure to remove non-viable tissue during surgical debridement. Maggots 
were placed in the wound for a total of 4 applications for complete debridement and 
granulation tissue migrated over his exposed bone.11 
  Case 5: An 80 year old female with a full thickness flame burn covering 7% TBSA burns 
was not a surgical candidate due to acute kidney injury and “a prohibitively high risk for 
surgical intervention” from heart complications. This patient was fully bio-debrided after 
2 MDT applications.12 
  Case 6: A 59 year old male involved in a traffic crush incident that was rescued from a 
hot furnace cinder, sustained burns to bilateral legs, buttock and perineal area 
encompassing 60% TBSA. After extensive escharotomy revealed 30% TBSA muscle 
necrosis the left leg was amputated. When skin allografting failed and infection was 
present, MDT was initiated to the existing wound sites for a total of 2 applications. The 
patient’s fever dropped within 24 hours of the first maggot application and he regained 
consciousness. After maggot removal of the second application, the necrotic tissue was 
debrided and “a bulk of fresh granulation tissue was seen on the wound” and this patient 
recovered without complications.13 
 Case 7: A 61 year old male type 1 diabetic with diabetic neuropathy and Charcot foot 
deformity sustained a right foot burn with 1% TBSA affected. This patient received a 
total of 3 MDT applications with successful debridement of the anterior wound surface 
with wound healing. The patient was noncompliant with his non-weight bearing status 
during MDT with subsequent difficulty maintaining the maggots within the dressing of 
the posterior aspect of the wound near the heel and underwent surgical debridement and 
grafting to this area.14 
DISCUSSION 
 Use of MDT fell out of favor for many years because of the utilization of antibiotics, but 
this old method is making a comeback in chronic non-healing wounds and this modality for the 
burn patient is a new area of research that warrants further investigation. Although MDT is not 
FDA approved for use in the burn population, these case reports clearly represent an efficient 
method for rapid and complete debridement of necrotic tissue in acute burn wounds. MDT takes 
2-3 days per application and provides a low cost alternative for wound bed preparation and 
should be an early consideration by clinicians for patients unable or unwilling to undergo 
surgical debridement.9 The additional benefit of infection control and degradation of biofilm is 
paramount as these complications are extremely difficult to treat and contribute to prolonged 
healing time and hospital stays or even failed grafts.9  
 Use of MDT can greatly reduce cost by avoiding exorbitant operating room and surgeon 
fees for wound debridement. According to Monarch Labs LLC, in Irvine, California, the cost of 
one vial of Medical Maggots is $190 and contains 250-500 larvae.15 See Figure II. The majority 
of the cost of this vial stems from the labor involved in the blowfly rearing process and the 
quality control of the laboratory.5 Besides the inexpensive cost of the vial, MDT can be 
performed on an outpatient basis with relative ease using overnight courier services which would 
further reduce length of hospital stays and improve the quality of life for these patients during 
their long recovery. MDT can give patients a viable treatment option alternative to surgical 
debridement that even improves their chance of recovery. 
 Some disadvantages are the negative public perspective that maggots are dirty and a 
misguided perception that larvae carry disease or cause further tissue damage. Medical personnel 
can be reluctant because of the aesthetics of maggots and find it distressing to remove the larvae 
from the wound which can be a difficult objection to overcome. Education on the therapeutic and 
economic benefits of this treatment can reduce the apprehension from the point of view of 
clinicians and patients alike. The BioTherapeutics, Education and Research (BTER) Foundation 
offers education, sample policies and procedures for use and disposal of the maggot dressings.5 
Furthermore, the patient needs to be cognizant enough to give consent to this therapy. Another 
limitation is that the wound cannot have copious drainage as this fluid will flush out the maggots 
and there is always the possibility that the maggots will escape the dressing. The BTER 
Foundation has easy to use specialized dressings to assist in maggot containment and reduces 
dressing application times for staff managing the wound care.8 While there seems to be great 
benefits and promising results associated with MDT from these case reports, it is not FDA 
approved for the use in acute burns further limiting the use in this population of patients.  
These case reports were assessed for quality using the GRADE with a score of very 
low.10 These reports lack consistent detailed accounts of the burn stage, size, extent of injury and 
outcomes. They had limited details without consistent maggot application frequency or dressing 
specifications. The number of MDT applications was reported but the time between applications 
was not indicated. It is evident that all patients within these case reports reviewed had successful 
debridement with maggots and could potentially replace surgical debridement prior to skin 
grafting. Having further studies that standardize this treatment procedure with detailed 
measureable parameters will result in more evidence-based outcomes that can be utilized in 
future research.  
Elements to consider in future studies would be detailing the wound size before and after 
each MDT application with percentages of necrotic vs. granulation tissue present in the wound 
bed recorded with a control group using standard dressing and surgical debridement. Perhaps 
performing a study with specific burn criteria limited to Stage IV with designation of a minimum 
% TBSA involved and a post procedure dressing protocol with daily wound measurements along 
with patient response via a 0-10 pain scale would enlist a great deal of useful information 
regarding the efficacy of maggot therapy. Random control trials (RTCs) could be performed in 
large burn centers with existing dressing protocols, using surgical debrided patients in the control 
group and MDT as the test group. Long term follow up after MDT is also necessary to assess 
outcome reliability. It is evident that all patients within these case reports reviewed had 
successful debridement with maggots and could potentially replace surgical debridement prior to 
skin grafting. Clearly, it requires further studies to investigate this modality in an evidence-based 
forum in order to enable the use of medicinal maggots in acute burn management as a standard 
treatment option.  
CONCLUSION 
 Based on these case reports, MDT should be considered in the burn patient population as 
a rapid, effective, safe and economical alternative modality for wound management. Maggot 
therapy for acute burn patients has received little attention in the research arena and is 
underutilized to date. There is a clear need for further studies in the acute burn population as 
MDT is effective at eliminating biofilm, promoting proliferation of granulation tissue and has 
excellent antimicrobial activity reducing wound infections. MDT can greatly reduce hospital cost 
and the treatment is easily accessible in the United States with the use of 24 hour overnight 
couriers. Patients who use this method also seem to have an increased chance of a successful 
recovery with less pain. Although more studies are needed to look at the benefits of MDT 
specific to the acute burn patient, the known benefits of MDT should warrant consideration of 
the patient and clinician alike who are open to a non-surgical alternative for effective wound 
debridement. Further evidence-based investigation to support medicinal maggot use in the acute 
burn patient is necessary before it can be integrated into the current standard of care with FDA 
approval for this population. Maggot therapy is an antiquated modality but this new area of 
research could greatly improve successful outcomes for burn victims and warrants immediate 
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Table I. Case Report Summary 
 















1 72/Male Upper Arm 4 3 weeks Yes 
2 32/Male Right Foot 5 51 days Yes 
3 64/Male Bilateral Knees 1 - No 
4 41/Male Bilateral Legs/ 
9%  
4 - Yes 
5 80/Female 7%  2 - Yes 
6 59/Male Bilateral Legs, 
Buttock, 
Perineum/ 60%  
2 - Yes 






Figure I. Photo of Wound Pre and Post MDT2 
 
 
Case 2 pre MDT2             Case 2 post MDT2 
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